APOA1 and Parkinson disease: However, only ApoA1 present in the EV fractions could be correlated with PD progression, as ApoA1-EV levels were decreased in PD patients with HY stage III versus HY stage II, while plasma protein levels of ApoA1 remained unchanged (141).